MITSUI & CO LTD - 22 Sep 2021 Form 3 Insider Report for Thorne Healthtech, Inc. (THRN)

Role: 10%+ Owner
Signature: /s/ Mitsui & Co., LTD., by /s/ Toshitaka Inuzuka, General Manager, NutriScience Division
Issuer symbol: THRN
Transactions as of: 22 Sep 2021
Transactions value $: $0
Form type: 3
Filing time: 22 Sep 2021, 18:10:47 UTC
Next filing: 29 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	THRN	Class A Common Stock						2,168,485	22 Sep 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	THRN	Series E Preferred Stock							22 Sep 2021	Class A Common Stock	13,505,750		Direct	F1, F2
holding	THRN	Class A Common Stock Warrant (Right to buy)							22 Sep 2021	Class A Common Stock	56,515	$5.12	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Immediately prior to the completion of the Issuer's initial public offering of Common Stock, the Class A Common Stock shall be re-named Common Stock.
F2	Each share of Series E Preferred Stock is currently convertible into Class A Common Stock on a one-for-one basis and has no expiration date. Each share of Series E Preferred Stock shall automatically convert into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering of Common Stock.
F3	All of the shares subject to the warrant are fully vested and exercisable as of the date hereof.